Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted Psychotherapy in Advanced Cancer
NCT05398484Phase 3Recruiting
- Sponsor
- NYU Langone Health
- Start
- May 2023
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of psilocybin in anxiety disorder, major depressive disorder (MDD), existential distress, sponsored by NYU Langone Health. Started May 2023; status: recruiting.
02
Drugs
psilocybin
03
Conditions
anxiety disordermajor depressive disorder (MDD)existential distress
Beyond the preview
Go deeper on NCT05398484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398484.